Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.

Abdulrazaq S Al-Jazairi Shahad RaslanRayd Al-MehiziaHani Al DalatyEdward B De VolElias SaadMosleh AlanaziTarek Owaidah

Published in: The Annals of pharmacotherapy (2020)

The adaption of a multifaceted anticoagulation protocol using anti-factor Xa assay may provide a better prediction of heparin dosing in adults ECMO patients compared with the conventional ACT-based protocol. Further studies are needed to assess the safety and different monitoring modalities.

Keyphrases

venous thromboembolism
randomized controlled trial
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
atrial fibrillation
high throughput